Showing results (1791-1800 of 1,877) with videos related to

Sort By:
Pageof 188
Nature Communications|December 12, 2022
Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculationGi Uk Jeong, Hyung-Jun Kwon, Wern Hann Ng, et al.
Annals of Surgery|May 5, 2018
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled studyYoon Young Choi, Hyunki Kim, Su-Jin Shin, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Bortezomib and the increased incidence of herpes zoster in patients with multiple myelomaSeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 16, 2022
Ocular motility disorders following coronavirus disease-19 vaccinationKyung-Ah Park, Hyeshin Jeon, Dong Gyu Choi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 StudyDo Young Kim, Chang-Ki Min, Hyeon-Seok Eom, et al.
Haematologica|July 29, 2010
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studySeok Jin Kim, Jong Wook Lee, Chul Won Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)Sung-Hoon Jung, Je-Jung Lee, Jin Seok Kim, et al.
Biomed Research International|July 5, 2014
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in KoreaHo Sup Lee, Kihyun Kim, Dok Hyun Yoon, et al.
Leukemia|March 24, 2020
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 studyPau Montesinos, Gail J Roboz, Claude-Eric Bulabois, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2025
Survival Benefits of Early Treatment With Blinatumomab in Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaDong Won Baek, Sang Kyun Sohn, Sung-Hoon Jung, et al.
Pageof 188